A computational model of coronary arteries with in-stent restenosis coupling hemodynamics and pharmacokinetics with growth mechanics [PDF]
Despite advances in stent technology, in-stent restenosis remains a critical challenge following percutaneous coronary intervention. In this work, we propose a comprehensive fluid-solid computational model to simulate restenosis after drug-eluting stent ...
Anna Ranno +13 more
doaj +2 more sources
Effect of Epicardial Adipose Tissue on In-stent Restenosis after Percutaneous Coronary Intervention: a Review [PDF]
As a major treatment for coronary artery disease, percutaneous coronary intervention (PCI) effectively enhances the survival rate of patients. However, the post-PCI in-stent restenosis has become a new cardiovascular problem that is difficult to solve ...
AN Jingjing, WANG Xiaojuan, DENG Aiyun
doaj +1 more source
PurposeAs a second-generation drug-eluting stent, the restenosis risk factors of the everolimus-eluting stent (EES) lack sufficient evidence. Therefore, the study investigated the in-stent restenosis occurrence and its predictive factors among patients ...
Qiang Feng +5 more
doaj +1 more source
Pathogenetic mechanisms of repeated adverse cardiovascular events development in patients with coronary heart disease: the role of chronic inflammation [PDF]
Stent restenosis is the most unfavorable complication of interventional treatment for coronary heart disease. We already know from various literature sources that the causes for stent restenosis in patients are both mechanical damage (partial opening ...
Irina Starodubtseva +2 more
doaj +3 more sources
Background Prognosis after vertebrobasilar stenting (VBS) may differ from that after carotid artery stenting (CAS). Here, we directly compared the incidence and predictors of in-stent restenosis and stented-territory infarction after VBS and compared ...
Jae-Chan Ryu +10 more
doaj +1 more source
Restenosis begets restenosis: implications for stent selection [PDF]
Identifying the risk for restenosis is of critical importance in the stent selection process of patients undergoing percutaneous coronary intervention (PCI). Therefore, we sought to determine if a history of clinical recurrence (CR) after PCI increases the risk of CR after treatment of a de novo lesion in another coronary artery.We retrospectively ...
Wijpkema, J. S. +5 more
openaire +3 more sources
Periodontitis Is Associated With Risk of Conventional Stent Restenosis: Pilot Case-Control Study
Objectives: Percutaneous coronary angioplasty with stent implantation has been established as the main form of treatment of atherosclerosis. However, 16 to 44% of patients may evolve with stent restenosis.
Raphael Osugue +6 more
doaj +1 more source
Purpose To investigate the safety and efficacy of Enterprise stent angioplasty and risk factors for the prognoses in treating symptomatic severe posterior circulation atherosclerotic stenosis (SSPCAS).
Zhi-Long Zhou +8 more
doaj +1 more source
Stent-in-Stent Endovascular Correction in Right Internal Carotid Artery Restenosis: a Clinical Case
Background. Carotid artery restenosis is a rare complication of carotid stenting. The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) reveals an in-stent restenosis rate of 0–6 %, a fairly low value given an extensive study ...
T. N. Khafizov +6 more
doaj +1 more source
Iron corroded granules inhibiting vascular smooth muscle cell proliferation
In-stent restenosis after interventional therapy remains a severe clinical complication. Current evidence indicates that neointimal hyperplasia induced by vascular smooth muscle cell (VSMC) proliferation is a major cause of restenosis.
Dongxu Qiu +9 more
doaj +1 more source

